PhD Opportunity in Preclinical PK-PD Modelling in Oncology at Medical University of Vienna Medical University of Vienna in Austria

PhD opportunity in preclinical pharmacokinetic-pharmacodynamic (PK-PD) modelling in oncology at the Medical University of Vienna, in cooperation with Boehringer Ingelheim International Company.

The project focuses on developing advanced mathematical and statistical models to understand dose-response relationships for anticancer drugs, improve translation from animal models to patients, and support more accurate clinical dose selection. This is a strong fit for candidates interested in pharmacy, pharmaceutical sciences, biomedical sciences, pharmacometrics, biostatistics, applied mathematics, and related quantitative life-science fields.

Preferred experience includes PK/PD modelling, statistical analysis, NONMEM, and R programming. The project is carried out in direct collaboration with the Preclinical PKPD Modelling Group at Boehringer Ingelheim in Vienna, offering exposure to both academic research and industrial drug development.

Funding is provided: the doctoral position is fully organized and funded, with a salary of about 2,832 euros per month gross, paid 14 times per year under the Austrian system.

Application deadline: 2026-07-28. Applicants should submit a motivational letter, CV, copy of Master's letter and any scientific publications, academic certificates and records, and contact details for 2-3 academic referees plus at least one recommendation letter.

Study location: Vienna, Austria.